Key result
Mice with a knock-in mutation making CaMKIIδ resistant to reactive oxygen species activation (MMVV) exhibited significantly reduced myocardial death and improved left ventricular function 24 hours after ischemia-reperfusion injury compared to wild-type controls.
Why the study?
ROS contribute to myocardial death during ischemia-reperfusion injury, but detailed knowledge of the molecular pathways connecting ROS to cardiac injury is lacking.
Preventing CaMKIIδ oxidation protects against ischemia-reperfusion injury by preserving KATP channel current, identifying ox-CaMKII as a key mediator of ROS-induced myocardial death.
Answers are grounded in this paper and cite their sources.
Ox-CaMKIIδ inhibition may confer cardioprotection; leaves open translation from mice to human ischemia-reperfusion injury.
Reactive oxygen species (ROS) contribute to myocardial death during ischemia-reperfusion (I/R) injury, but detailed knowledge of molecular pathways connecting ROS to cardiac injury is lacking. Activation of the Ca 2+ /calmodulin-dependent protein kinase II (CaMKIIδ) is implicated in myocardial death, and CaMKII can be activated by ROS (ox-CaMKII) through oxidation of regulatory domain methionines (Met281/282). We examined I/R injury in mice where CaMKIIδ was made resistant to ROS activation by knock-in replacement of regulatory domain methionines with valines (MMVV). We found reduced myocardial death, and improved left ventricular function 24 hours after I/R injury in MMVV in vivo and in vitro compared to WT controls. Loss of ATP sensitive K + channel (KATP) current contributes to I/R injury, and CaMKII promotes sequestration of KATP from myocardial cell membranes. KATP current density was significantly reduced by H 2 O 2 in WT ventricular myocytes, but not in MMVV, showing ox-CaMKII decreases KATP availability. Taken together, these findings support a view that ox-CaMKII and KATP are components of a signaling axis promoting I/R injury by ROS.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2019) studied Myocardial ischemia-reperfusion injury. CaMKIIδ oxidation resistance (MMVV knock-in mutation) vs. Wild-type (WT) mice was evaluated on Myocardial death (Area of necrosis / Area at risk) after I/R injury (p=<0.05). Mice with a knock-in mutation making CaMKIIδ resistant to reactive oxygen species activation (MMVV) exhibited significantly reduced myocardial death and improved left ventricular function 24 hours after ischemia-reperfusion injury compared to wild-type controls.
Synapse has enriched 10 related papers. Consider them for comparative context: